Juliana Miki Oguma

Mrs. Juliana Miki Oguma


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ANArtur Francisco da Silva Neto
Artur Francisco da Silva Neto
JRJúlia Ferreira Rocha
Júlia Ferreira Rocha
GLGustavo Oliveira Lima
Gustavo Oliveira Lima
JOJuliana Miki Oguma
Juliana Miki Oguma
VPVivien Cayres Giarola Suannes Pucci
Vivien Cayres Giarola Suannes Pucci
LOLila M. Oyama
Lila M. Oyama
C-phycocyanin (CPC), a bioactive compound derived from Spirulina, has been described as a molecule with antioxidant and anti-inflammatory properties. It has also been demonstrated that sustainably obtained CPC effectively inhibited body mass gain, regulated serum leptin and resistin levels, and prevented the onset of a pro-inflammatory state in Swiss mice fed a hyperlipidic diet. These results highlighted the anti-obesogenic potential of CPC. Brown adipose tissue (BAT) has been identified as a promising target in the treatment of obesity, playing a role in energy expenditure. In this study, Swiss mice fed a high-fat diet were supplemented with 500 mg/kg body weight of CPC daily for 12 and 16 weeks. BAT was collected, and Western blot and ELISA were performed. A reduction in pro-inflammatory cytokines, as well as a decrease in leptin levels was observed in the tissue, which was also associated with a reduction in BAT relative weight to body mass. Furthermore, CPC administration was able to modulate uncoupling protein 1 (UCP1) levels, which is crucial in the thermogenesis process. Therefore, this study demonstrated that supplementation with CPC reduces inflammatory cytokines associated with detrimental effects in the BAT, emerging as a tool in combating obesity and improving BAT function.

3 August 2025 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
LILetícia Miyuki Ito
Letícia Miyuki Ito
JOJuliana Miki Oguma
Juliana Miki Oguma
AMAndre Kiyoshi Miyahara
Andre Kiyoshi Miyahara
MVMarco Aurélio Sales da Veiga
Marco Aurélio Sales da Veiga
LFLeandro Favaro
Leandro Favaro
ERErika Rangel
Erika Rangel
Introduction: Renal malacoplakia is a rare chronic granulomatous disease, often associated with immunosuppression and persistent Gram-negative infections, particularly Escherichia coli. Case Presentation: We present a case involving a 31-year-old woman with hypertension, gestational diabetes, and prior uterine curettage after labor induction for preeclampsia at 23 weeks. She developed urinary sepsis post-procedure. Imaging revealed bilateral nephromegaly, while laboratory tests showed acute kidney injury (KDIGO stage III), anemia, and thrombocytopenia. Blood and urine cultures grew Escherichia coli. Renal biopsy confirmed malacoplakia, demonstrating PAS-positive Michaelis–Gutmann bodies and Von Hansemann cells. The patient responded to prolonged antibiotic therapy and supportive care. Discussion and Conclusion: This case highlights the importance of considering renal malacoplakia in patients with atypical urinary tract infections and nephromegaly, particularly in obstetric settings. Histopathological confirmation is essential, and timely treatment with intracellularly active antibiotics can lead to favorable outcomes. Early diagnosis is critical to prevent irreversible renal damage.